Swiss stocks - Factors to watch on April 16

ZURICH/BERLIN, April 16 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent higher at 9,537 points on Tuesday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:

NOVARTIS

The Swiss drugmaker announced that U.S. regulators had accepted its filing for Brolucizumab for patients with macular degeneration and that it is expecting to launch the drug by the end of the year, if it is approved